Is Eli Lilly a stock?

Eli Lilly and Company is a drug manufacturers-general business based in the US. Eli Lilly and Company shares (LLY) are listed on the NYSE and all prices are listed in US Dollars. Eli Lilly and Company employs 39,000 staff and has a trailing 12-month revenue of around $27.7 billion. Choose a stock trading platform.

When will Eli Lilly announce its second-quarter 2023 financial results?

Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2023 financial results on Tuesday, Aug. 8, 2023. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.

Can Eli Lilly Eclipse $1 trillion by 2033?

Two companies that I can see eclipsing $1 trillion by 2033 are Eli Lilly (NYSE: LLY) and UnitedHealth Group (NYSE: UNH). Eli Lilly's market capitalization is at $425 billion today. One big opportunity for the company is in weight loss, where Eli Lilly has not just one but multiple promising products.

Does Eli Lilly's obesity drug help people lose weight?

Eli Lilly said on Thursday its experimental obesity drug helped patients reduce 26.6% of weight, on average, across two late-stage studies after intensive lifestyle changes or with continued treatment, before they stopped taking the drug.